UBS Group AG - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 80 filers reported holding FORTRESS BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$6,601
+131920.0%
22,760
+252788.9%
0.00%
Q2 2023$5
-99.9%
9
-99.8%
0.00%
Q1 2023$3,364
+55966.7%
4,103
+45488.9%
0.00%
Q4 2022$6
-99.7%
9
-99.6%
0.00%
Q3 2022$2,0000.0%2,141
+58.7%
0.00%
Q1 2022$2,000
-96.4%
1,349
-93.9%
0.00%
Q4 2021$56,000
+5500.0%
22,183
+7294.3%
0.00%
Q3 2021$1,000
-98.0%
300
-97.8%
0.00%
Q2 2021$50,000
-13.8%
13,938
-14.3%
0.00%
Q1 2021$58,000
+23.4%
16,272
+8.8%
0.00%
Q4 2020$47,000
+683.3%
14,959
+903.3%
0.00%
Q3 2020$6,000
-89.8%
1,491
-93.2%
0.00%
Q2 2020$59,000
+2850.0%
21,921
+2092.1%
0.00%
Q1 2020$2,000
-33.3%
1,0000.0%0.00%
Q4 2019$3,000
-95.8%
1,000
-98.0%
0.00%
Q3 2019$72,000
+2300.0%
51,000
+3341.3%
0.00%
Q2 2019$3,000
+50.0%
1,482
+48.2%
0.00%
Q1 2019$2,000
-83.3%
1,000
-92.9%
0.00%
Q4 2018$12,000
-29.4%
14,149
+35.4%
0.00%
Q3 2018$17,000
+6.2%
10,452
+95.9%
0.00%
Q2 2018$16,0000.0%5,336
+60.9%
0.00%
Q1 2018$16,000
+60.0%
3,316
+31.7%
0.00%
Q4 2017$10,000
-52.4%
2,518
-47.5%
0.00%
Q3 2017$21,000
+40.0%
4,794
+54.7%
0.00%
Q2 2017$15,000
-90.6%
3,098
-92.9%
0.00%
Q1 2017$160,000
+33.3%
43,375
-2.8%
0.00%
Q4 2016$120,000
+2.6%
44,631
+13.6%
0.00%
Q3 2016$117,000
-1.7%
39,300
-11.1%
0.00%
Q2 2016$119,000
-68.0%
44,207
-63.2%
0.00%
Q1 2016$372,000
+235.1%
120,047
+202.7%
0.00%
Q4 2015$111,000
-0.9%
39,661
-8.0%
0.00%
Q3 2015$112,000
+1144.4%
43,131
+1440.4%
0.00%
Q2 2015$9,0002,8000.00%
Other shareholders
FORTRESS BIOTECH INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,887,500$12,323,0001.61%
Nantahala Capital Management 8,680,909$27,518,0000.85%
SHIKIAR ASSET MANAGEMENT INC 558,500$1,770,0000.64%
CPWM, LLC 506,267$1,605,0000.15%
Sandbox Financial Partners, LLC 14,650$46,0000.04%
Sepio Capital, LP 134,748$427,0000.04%
683 Capital Management, LLC 200,000$635,0000.03%
GSA CAPITAL PARTNERS LLP 22,928$73,0000.01%
Virtu Financial LLC 33,333$106,0000.01%
B. Riley Wealth Advisors, Inc. 55,510$176,0000.01%
View complete list of FORTRESS BIOTECH INC shareholders